Jennifer A. DoudnaWe founded Editas Medicine with $43 million in financing from three venture capital firms.
About This Quote
Editas Medicine is a venture capital backed biotech company that was founded by Dr. Ido's son, Dr. Daniel. Editas Medicine is developing treatments for the most common and devastating forms of human genetic diseases and disorders. Their focus is on developing treatments for people with sickle cell disease and cystic fibrosis.
Source: A Crack In Creation: Gene Editing And The Unthinkable Power To Control Evolution
Some Similar Quotes
- The problem, often not discovered until late in life, is that when you look for things in life like love, meaning, motivation, it implies they are sitting behind a tree or under a rock. The most successful people in life recognize, that in life they...
- And sometimes I believe your relentless analysis of June leaves something out, which is your feeling for her beyond knowledge, or in spite of knowledge. I often see how you sob over what you destroy, how you want to stop and just worship; and you...
- The saddest aspect of life right now is that science gathers knowledge faster than society gathers wisdom.
- I'm sure the universe is full of intelligent life. It's just been too intelligent to come here.
- A man who dares to waste one hour of time has not discovered the value of life.
More Quotes By Jennifer A. Doudna
- In 2011, Rachel and I founded a company called Caribou Biosciences to commercialize the Cas proteins.
- Editas Medicine has an exclusive multimillion-dollar license with Juno Therapeutics to develop T cell therapies
- PGD has also been used for other controversial purposes, such as the birth if so-called savior siblings, destined from the moment of implantation not only to live their own lives, but also to serve as organ or cell donors for a sibling.
- We founded Editas Medicine with $43 million in financing from three venture capital firms.
- As we began discussing authorship of a white paper summarizing our conclusions, we debated who our target audience should be and what kind of outcome we were hoping to achieve.